ACM
TTOO

Altium Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Altium Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-568
Closed -$321K – 139
2022
Q3 		$321K Buy
+568
New +$374K 0.12% 97

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Altium Capital Management's TTOO Position: Q4 2022 in Review

Altium Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 568 shares — an estimated $321K sold.

Altium Capital Management first reported a position in TTOO in Q3 2022 and held it in 1 quarter. The position peaked at $321K in Q3 2022. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Altium Capital Management reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Altium Capital Management sold 568 T2 Biosystems, Inc shares in Q4 2022, an estimated $321K.
  • Altium Capital Management first reported a position in T2 Biosystems, Inc in Q3 2022 and held it in 1 quarter.
  • Altium Capital Management's T2 Biosystems, Inc position peaked at $321K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.